Azobenzene

Azobenzene

SCHEMBL32684293

C=C(C)C(=O)O.C=C(C)C(=O)O.c1ccc(N=Nc2ccccc2)cc1

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.55
RAB9A P51151 4/20 0.55
NPC1 O15118 4/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
ALDH1A1 P00352 4/20 0.55
TRPA1 O75762 1/20 0.54
CASP3 P42574 1/20 0.50
SENP8 Q96LD8 1/20 0.50
SENP7 Q9BQF6 1/20 0.50
SENP6 Q9GZR1 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
MEN1 O00255 5/20 0.48
KMT2A Q03164 5/20 0.48
KDM4E B2RXH2 3/20 0.45
MAPK1 P28482 2/20 0.45
TDP1 Q9NUW8 2/20 0.45
HSP90AA1 P07900 1/20 0.45
POLB P06746 1/20 0.45
CYP2D6 P10635 1/20 0.45
HTT P42858 3/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Azobenzene SCHEMBL28067709 1.00 MAPT (0.55) MAPTRAB9ANPC1SMN1; SMN2ALDH1A1
Azobenzene SCHEMBL28067708 1.00 MAPT (0.55) MAPTRAB9ANPC1SMN1; SMN2ALDH1A1
Methacrylic Acid SCHEMBL28228637 0.89 MAPT (0.46) MAPTRAB9ANPC1SMN1; SMN2ALDH1A1
Azobenzene SCHEMBL14690352 0.87 MAPT (0.52) MAPTRAB9ANPC1SMN1; SMN2ALDH1A1
Azobenzene SCHEMBL8576139 0.87 MAPT (0.52) MAPTRAB9ANPC1SMN1; SMN2ALDH1A1
Azobenzene SCHEMBL29154401 0.85 ALDH1A1 (0.67) MAPTRAB9ANPC1SMN1; SMN2ALDH1A1
SCHEMBL27947436 0.82 TRPA1 (0.60) MAPTRAB9ANPC1SMN1; SMN2ALDH1A1
Methacrylic Acid SCHEMBL554250 0.82 MAPT (0.58) MAPTRAB9ANPC1SMN1; SMN2ALDH1A1
Azobenzene SCHEMBL9435350 0.80 ALDH1A1 (0.75) MAPTRAB9ANPC1SMN1; SMN2ALDH1A1
Azobenzene SCHEMBL475771 0.80 ALDH1A1 (0.75) MAPTRAB9ANPC1SMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260072020-A1 PRINTABLE MOLECULE-SELECTIVE CORE-SHELL NANOPARTICLES FOR WEARABLE AND IMPLANTABLE SENSING CALIFORNIA INST OF TECHN (US) 2026-03-12 US claimed
US-20260072020-A1 PRINTABLE MOLECULE-SELECTIVE CORE-SHELL NANOPARTICLES FOR WEARABLE AND IMPLANTABLE SENSING CALIFORNIA INST OF TECHN (US) 2026-03-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260072020-A1 PRINTABLE MOLECULE-SELECTIVE CORE-SHELL NANOPARTICLES FOR WEARABLE AND IMPLANTABLE SENSING MIF, HMOX2, HMOX1 MAPT 3003/4885RAB9A 3046/4885NPC1 3437/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.